Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-04

Clinical Trial Update: Effect of Furosemide on Obesity-induced Glomerular Hyperfiltration [NA]

View source ↗

Summary

A clinical trial studied the effect of furosemide on obesity-induced glomerular hyperfiltration. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: Rabin Medical Center | Conditions: Obesity-induced Hyperfiltration | NA | Status: TERMINATED